Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPhathom Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.51 | -$1.12 | -$1.32 |
| Q2 2024 | 1 | -$1.50 | -$1.12 | -$1.32 |
| Q3 2024 | 1 | -$1.67 | -$1.24 | -$1.47 |
| Q4 2024 | 2 | -$1.37 | -$1.02 | -$1.21 |
| Q1 2025 | 1 | -$1.36 | -$1.01 | -$1.19 |
| Q2 2025 | 1 | -$1.20 | -$0.89 | -$1.05 |
| Q3 2025 | 1 | -$1.06 | -$0.79 | -$0.93 |
| Q4 2025 | 1 | -$0.90 | -$0.67 | -$0.79 |
Phathom Pharmaceuticals, Inc. Earnings Date And Information
Phathom Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-1.32 earnings per share for the quarter, topping analysts' consensus estimates of $-1.57 by $0.25. The company had revenue of 16.35 M for the quarter and had revenue of 682,000 for the year. Phathom Pharmaceuticals, Inc. has generated $-4 earnings per share over the last year ($-3.93 diluted earnings per share) and currently has a price-to-earnings ratio of -1.56. Phathom Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Phathom Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$1.57 | -$1.32 | 0.25 | $12.61 M | $16.35 M |
| 08/08/2024 | Q2 2024 | -$1.20 | -$1.56 | -0.36 | $5.68 M | $7.32 M |
| 06/14/2024 | Q1 2024 | -$1.42 | $1.91 M | |||
| 06/14/2024 | Q4 2023 | -$1.39 | $682,000 | |||
| 11/09/2023 | Q3 2023 | -$0.95 | -$0.76 | 0.19 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.95 | -$0.84 | 0.11 | $0 | |
| 05/10/2023 | Q1 2023 | -$1.34 | -$0.89 | 0.45 | $0 | |
| 02/28/2023 | Q4 2022 | -$1.50 | -$1.54 | -0.04 | $0 | |
| 11/08/2022 | Q3 2022 | -$1.54 | $0 | |||
| 08/02/2022 | Q2 2022 | -$1.03 | -$1.33 | -0.3 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.97 | -$1.14 | -0.17 | $0 | |
| 03/01/2022 | Q4 2021 | -$0.86 | -$0.95 | -0.09 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.78 | -$0.98 | -0.2 | $0 | |
| 08/10/2021 | Q2 2021 | -$1.07 | -$1.00 | 0.07 | $0 | |
| 05/11/2021 | Q1 2021 | -$1.11 | -$0.96 | 0.15 | $0 | |
| 03/30/2021 | Q4 2020 | -$0.93 | -$1.58 | -0.65 | $0 | |
| 11/10/2020 | Q3 2020 | -$0.68 | -$1.02 | -0.34 | $0 | |
| 08/06/2020 | Q2 2020 | -$0.56 | -$0.64 | -0.08 | $0 | |
| 05/12/2020 | Q1 2020 | -$0.59 | -$0.62 | -0.03 | $0 | |
| 03/19/2020 | Q4 2019 | -$1.25 | -$3.02 | -1.77 | $0 |
Phathom Pharmaceuticals, Inc. Earnings: FAQ's
When is Phathom Pharmaceuticals, Inc.'s earnings date?
Phathom Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
Did Phathom Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Phathom Pharmaceuticals, Inc. (:PHAT) reported $-1.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.57 by $0.25.
How can I listen to Phathom Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Phathom Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Phathom Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Phathom Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much revenue does Phathom Pharmaceuticals, Inc. generate each year?
Phathom Pharmaceuticals, Inc. (:PHAT) has a recorded annual revenue of $682,000.
How much profit does Phathom Pharmaceuticals, Inc. generate each year?
Phathom Pharmaceuticals, Inc. (:PHAT) has a recorded net income of $682,000. Phathom Pharmaceuticals, Inc. has generated $-3.93 earnings per share over the last four quarters.
What is Phathom Pharmaceuticals, Inc.'s price-to-earnings ratio?
Phathom Pharmaceuticals, Inc. (:PHAT) has a price-to-earnings ratio of -1.56 and price/earnings-to-growth ratio is 0.14.